150-Year-old Drug May Improve Radiation Therapy for Cancer: Study

150-Year-old Drug May Improve Radiation Therapy for Cancer: Study

“}var y=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;$(“#main_score_strip_top”).html(y),set_score_slider_style()}else $(“#top_strip_cricket_widget”).html(“https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”),”undefined”!=typeof updateTopScoreWidgetNews18&&clearInterval(updateTopScoreWidgetNews18),console.log(“no live match in progress”)},error:function(e){console.log(“error in live score widget”),$(“#top_strip_cricket_widget”).html(“https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”)}})} function get_live_team_scores(e,s,i){var e=get_ipl_teams_short(e),t=s,i=i,a=”https://images.news18.com/static_news18/ibnlive/pix/ibnhome/cricketnext/microsite/teamsicon/”,r=a+e.toLowerCase()+”.png”,n=’‘,c=t.length;if(c>0){for(var o=1,v=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”,l=0;c>l;l++){var m=t[l].scores,p=t[l].wickets,f=t[l].overs,g=t[l].active;if(1==g)var d=”“,_=”“;else d=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”,_=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;if(2==o)var b=” & “;else var b=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;”test”==i?(v=v+”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”+b+d+m+”/”+p+_,o+=1):(v=v+”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”+d+m+”/”+p+”(“+f+”)”+_+b,o+=1)}var h=d+e+_;h=’ ‘+n+h+v+” “}else h=”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”;return h} function convertToSlug(e){return e.replace(” (W)”,”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”).replace(” (C)”,”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”).toLowerCase().replace(/[^w ]+/g,”https://genericmedicine.com/wp-content/uploads/2018/10/150-Year-old-Drug-May-Improve-Radiation-Therapy-for-Cancer-Study.com”).replace(/ +/g,”-“)} function get_ipl_teams_short(a){var r=new Array;return r.Kolkata=”KKR”,r.KOL=”KKR”,r.MUM=”MI”,r.Mumbai=”MI”,r.HYD=”SRH”,r.Hyderabad=”SRH”,r.PUN=”RPS”,r.Punjab=”KXIP”,r.PNJ=”KXIP”,r.Bangalore=”RCB”,r.BLR=”RCB”,r.Delhi=”DD”,r.DEL=”DD”,r.Pune=”RPS”,r.Gujarat=”GL”,r.GUJ=”GL”,r.TBC=”TBC”,a in r?r[a]:a} var updateTopScoreWidgetNews18=setInterval(function(){news18_top_widget_live_scores() }, 20000);}); Researchers from Ohio State University (OSU) in the […]

Novartis spends $2.1B to snap up targeted radiotherapy drug for prostate cancer

Novartis spends $2.1B to snap up targeted radiotherapy drug for prostate cancer

Swiss drugmaker Novartis made a big investment in radiopharmaceuticals with the Thursday announcement that it will acquire a US firm with an oncology drug in late-stage development. The company said it would acquire Endocyte, headquartered in West Lafayette, Indiana, for $2.1 billion, or $24 per share. The company has a radioligand therapy, Lu-PSMA-617, in Phase […]

Dawn Picken: A miracle cancer drug has given a friend new life

Dawn Picken: A miracle cancer drug has given a friend new life

Joanne Rye-McGregor is back from the dead. My friend greets me with a hug at Back Porch Cafe in central Mount Maunganui. As she walks, long grey curls brush her shoulders. Jo is 56 years old. She’s sinew and bone, her once medium frame lighter by about 20 kilograms. Cancer does that. When I saw […]

A Year Early, Merck Touts Good Kidney Cancer News to Push Rival BMS

A Year Early, Merck Touts Good Kidney Cancer News to Push Rival BMS

Xconomy New York —  Merck could soon join rival Bristol-Myers Squibb in making immunotherapy an option for kidney cancer patients who have never had treatment before. Merck (NYSE: MRK) reported today that its blockbuster pembrolizumab (Keytruda) has hit its marks much earlier than expected in an 861-person Phase 3 study called Keynote-426. Merck tested a […]

150-Year-Old Drug Could Improve Cancer Radiation Therapy

150-Year-Old Drug Could Improve Cancer Radiation Therapy

A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). The researchers found […]

Relief for cancer patients! 150-year-old drug may improve radiation therapy, says study

Relief for cancer patients! 150-year-old drug may improve radiation therapy, says study

Researchers from Ohio State University (OSU) in the US found that the drug called papaverine, inhibits the respiration of mitochondria, the oxygen-consuming and energy-making components of cells, and sensitises model tumours to radiation. A drug first identified 150 years ago and used as a smooth-muscle relaxant could make tumours more sensitive to radiation therapy, according […]

Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion

Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion

Novartis AG on Thursday said it would buy cancer-drug maker Endocyte Inc. for $2.1 billion, the Swiss pharmaceutical giant’s latest move to refocus on higher-value medicines. Novartis said it would pay $24 a share for the U.S.-based company, which has a focus on prostate cancer—an area with significant unmet medical need. It said the deal […]